Hao-wen W. Sim

370 Victoria St
Darlinghurst, NSW 2010, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Aggressive pituitary neuroendocrine tumours display a distinct immune microenvironment.

Aggressive pituitary neuroendocrine tumours display a distinct immune microenvironment.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 20, 2026

Impact of an evolving classification system on diffuse glioma repositories: experience from the Sydney brain tumour bank.

Impact of an evolving classification system on diffuse glioma repositories: experience from the Sydney brain tumour bank.

Journal: Journal of neuro-oncology

Published: October 31, 2025

Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-Oncology.

Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-Oncology.

Journal: Asia-Pacific journal of clinical oncology

Published: October 26, 2025

Clinical outcomes and management of CDKN2A/B homozygously deleted IDH-mutant astrocytomas-a cohort study and patterns of care survey.

Clinical outcomes and management of CDKN2A/B homozygously deleted IDH-mutant astrocytomas-a cohort study and patterns of care survey.

Journal: Neuro-oncology practice

Published: October 13, 2025

Aggressive pituitary tumours and pituitary carcinomas: molecular insights guiding management and the role of precision oncology.

Aggressive pituitary tumours and pituitary carcinomas: molecular insights guiding management and the role of precision oncology.

Journal: Molecular and cellular endocrinology

Published: March 18, 2025

Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.

Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.

Journal: Science advances

Published: March 12, 2025

Efficacy of systemic therapy in metastatic adrenocortical carcinoma: a meta-analysis of prospective clinical trials.

Efficacy of systemic therapy in metastatic adrenocortical carcinoma: a meta-analysis of prospective clinical trials.

Journal: Endocrine oncology (Bristol, England)

Published: March 11, 2025

A Systematic Review and Meta-Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid Tumours.

A Systematic Review and Meta-Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid Tumours.

Journal: Cancer medicine

Published: February 14, 2025

Real-world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience.

Real-world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience.

Journal: BJUI compass

Published: February 11, 2025

Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 glioma.

Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 glioma.

Journal: BMJ open

Published: February 10, 2025

Chemotherapy and radiotherapy for advanced pancreatic cancer.

Chemotherapy and radiotherapy for advanced pancreatic cancer.

Journal: The Cochrane database of systematic reviews

Published: December 05, 2024

A phase II trial of larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA overexpression identified by comprehensive genomic profiling.

A phase II trial of larotrectinib in tumors with NTRK fusions or extremes of NTRK mRNA overexpression identified by comprehensive genomic profiling.

Journal: The oncologist

Published: August 28, 2024

Showing 1-12 of 68

Last Updated: 09/26/2026